Clínic Barcelona

A preclinical trial by the U.S. National Institutes of Health validates the efficacy of Uric Acid for ischaemic stroke

Uric Acid was shown to improve the prognosis of ischaemic stroke in a preclinical study carried out on rodents within the framework of the Stroke Preclinical Assessment Network (SPAN) in the USA, a network of experimental laboratories focusing on cerebral ischaemia, coordinated by the Keck School of Medicine of the University of Southern California (USC).

Dr. Angel Chamorro (left) and Carlos Lurigados

Dr. Angel Chamorro (left) and Carlos Lurigados

Related contents
Keep reading about:

Related news